Jennison Associates LLC Adma Biologics, Inc. Transaction History
Jennison Associates LLC
- $162 Billion
- Q4 2024
A detailed history of Jennison Associates LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 44,640 shares of ADMA stock, worth $883,872. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,640
Previous 34,515
29.34%
Holding current value
$883,872
Previous $689,000
11.03%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$369 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$360 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$294 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$224 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$110 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.89B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...